Guardian Pharmacy Services, Inc. 8-K

What Happened

• Guardian Pharmacy Services, Inc. filed an 8-K reporting that it completed an underwritten public offering on March 20, 2026 of 6,900,000 Class A shares (5,880,000 selling stockholder shares and 1,020,000 newly issued company shares) at a $31.00 public offering price per share (underwriting discount $1.3175).
• The Company used all net proceeds from the 1,020,000 Company Shares to repurchase 1,020,000 outstanding Class A shares from certain holders under Stock Purchase Agreements dated March 18, 2026; those repurchased shares were cancelled, resulting in no change to total Class A shares outstanding.
• The Company entered Stock Purchase Agreements on March 18, 2026 to purchase, using proceeds from one or more underwritten public offerings, up to an aggregate of 1,833,344 Class A shares (purchase price = public offering price less underwriting discount). The agreements include a lock-up by the selling holders ending on the later of June 30, 2026 or 180 days after the date of the latest underwriting agreement entered on or before June 30, 2026.
• As a result of the Offering, the selling stockholders no longer hold a majority of the voting power and the Company ceased to qualify as a “controlled company” under NYSE rules; effective March 20, 2026 the Board established a Nominating and Governance Committee and named Steven Cosler, Randall Lewis and Mary Sue Patchett (chair) as members, each determined to be independent.

Key Details

• Offering size: 6,900,000 total shares (5,880,000 selling; 1,020,000 company).
• Public offering price: $31.00 per share; underwriting discount: $1.3175 per share.
• Company used proceeds to repurchase and cancel 1,020,000 shares (non-dilutive to outstanding Class A).
• Stock Purchase Agreements allow purchases up to 1,833,344 shares and impose a lock-up through at least June 30, 2026 (or 180 days after the last underwriting agreement entered by then).

Why It Matters

• Governance: Losing “controlled company” status means Guardian must comply with additional NYSE corporate governance requirements (and has already created a Nominating and Governance Committee), which can affect board composition and oversight.
• Capital structure: The Company conducted a synthetic secondary (company sold new shares and used proceeds to buy and cancel outstanding shares), so the transaction was non-dilutive to Class A outstanding shares and did not increase the share count.
• Shareholder liquidity and restrictions: The Stock Purchase Agreements and lock-up limit disposition of additional shares by the participating holders for a defined period, which can affect near-term float and potential selling pressure.